The interaction between recombinant OFD1 and E2F4 was further validated by endogenous immunoprecipitation (IP) in three pancreatic cancer cell lines (Fig. 6e) and an in vitro pulldown assay (Supplementary Fig. 6i,,  j). This evidence concerns the gene OFD1 and familial pancreatic carcinoma.